Table 2.
Hepatic function outcomes during and after HCV treatment in patients awaiting LT for decompensated cirrhosis.
| Variable | Baseline | Week 24 | Week 12 after End of Treatment | One Year Post-Treatment | Two Years Post-Treatment |
|---|---|---|---|---|---|
| MELD score Median (IQR) |
14 (11; 18) |
13 (9.5; 16) |
12 (9; 15) |
11 (8; 13) |
9 (8; 12) |
| Child Pugh class, n (%) | |||||
| A | 15 (20) | 20 (37.7) | 32 (49.2) | 31 (70.5) | 29 (78.4) |
| B | 30 (40) | 21 (39.6) | 22 (33.9) | 8 (18.2) | 8 (21.6) |
| C | 30 (40) | 12 (22.6) | 11 (16.9) | 5 (11.4) | 0 (0) |
HCV: hepatitis C virus; LT: liver transplantation; MELD: Model for End-Stage Liver Disease.